Skip to main content

Table 3 Description of prevalence of each subset

From: Enrichment Bayesian design for randomized clinical trials using categorical biomarkers and a binary outcome

Number of subsets Subset A Subset B Subset C
2 0.2 0.8  
  0.4 0.6  
  0.6 0.4  
  0.8 0.2  
3 1/3 1/3 1/3
  1/6 1/3 2/4
  11/18 1/3 1/18
  1/3 2/4 1/6
  1/3 1/18 11/18